Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

Scopus by Title (Ref)

1. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma

- Chan Y.T. , et al.

2. Glypican-3, Vascular Endothelial Growth Factor and Golgi Protein-73 for Differentiation between Liver Cirrhosis and Hepatocellular Carcinoma

- Mamdouh S. , et al.

3. European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation

- Berenguer M. , et al.

4. Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?

- Gonvers S. , et al.

5. The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma

- Yi B. , et al.

6. The value of contrast-enhanced ultrasound in predicting postoperative recurrence of hepatocellular carcinoma: A protocol for systematic review and meta-analysis

- Fu J. , et al.

7. Serum-derived exosomes function as tumor antigens in patients with advanced hepatocellular carcinoma

- Shi S. , et al.

8. Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation

- Mo Y. , et al.

9. Developments in predictive biomarkers for hepatocellular carcinoma therapy

- Andrea C.G. , et al.

10. Independent risk factors for disease recurrence after surgery in patients with hepatitis B virus-related hepatocellular carcinoma 3 cm in diameter

- He L.L. , et al.

11. Meta-analysis and systematic review of prognostic significance of Glypican-3 in patients with hepatitis B-related hepatocellular carcinoma

- Moudi B. , et al.

12. A twenty-year review of clinical liver transplantation

- Zhongyang S. , et al.

13. Compliance with ethical standards in the reporting of donor sources and ethics review in peer-reviewed publications involving organ transplantation in China: A scoping review

- Rogers W. , et al.

14. Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma an updated meta-analysis

- Zhang J. , et al.

15. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment

- Zhou F. , et al.

16. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma

- Yin F. , et al.

17. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance

- Yang L. , et al.

18. Association of histone methyltransferase G9a and overall survival after liver resection of patients with hepatocellular carcinoma with a median observation of 40 months

- Bai K. , et al.

19. Advances in the study of oncofetal antigen glypican-3 expression in HBV-related hepatocellular carcinoma

- Yao M. , et al.

20. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/catenin signaling pathway

- Gai J.Q. , et al.

21. AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis

- Jin J. , et al.

22. Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma

- Wang L. , et al.

23. Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells

- Wang Y. , et al.

24. Silencing of the glypican-3 gene affects the biological behavior of human hepatocellular carcinoma cells

- Qi X.H. , et al.

25. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy

- Han L.L. , et al.